Trial intelligence / Profile preview

Vitamin D supplementation and glucose handling (D-clamp)

NCT00809744Phase 2Completed

Sponsor
University Hospital of North Norway
Start
Nov 2008
Primary completion
Dec 2010
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of vitamin d in insulin resistance (IR), sponsored by University Hospital of North Norway. Primary endpoint: insulin secretion at 6 months. Started Nov 2008; status: completed.

02

Drugs

vitamin d
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT00809744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00809744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call